Newsletter Archive
-
03.14.23 -- Top Pharma Continues To Choose A Unified Platform Approach In 2023
3/14/2023
03/14/23 Clinical Leader Newsletter
-
03.13.23 -- Pfizer Exec On Pharma's Role In Improving Health Literacy
3/13/2023
03/13/23 Clinical Leader Newsletter
-
03.10.23 -- FDA Guidance Addresses Data Considerations For Externally Controlled Trials
3/10/2023
03/10/23 Clinical Leader Newsletter
-
03.10.23 -- Partners Ready To Support Your Phase I-III Trials
3/10/2023
03/10/23 Clinical Leader Newsletter
-
03.09.23 -- FDA Vs. EMA: Comparing Cell & Gene Therapy Requirements
3/9/2023
03/09/23 Clinical Leader Newsletter
-
03.09.23 -- Efficient Clinical Supply Management And Forecasting
3/9/2023
03/09/23 Clinical Leader Newsletter
-
03.08.23 -- Walgreens Exec: “Optionality” Is The Way Forward For Hybrid Trials
3/8/2023
03/08/23 Clinical Leader Newsletter
-
03.07.23 -- Questions Sponsors Should Ask When Selecting Tech Vendors For DCTs
3/7/2023
03/07/23 Clinical Leader Newsletter
-
03.07.23 -- A New Solution For Multisite Research
3/7/2023
03/07/23 Clinical Leader Newsletter
-
03.06.23 -- Are DCTs Saving Sites Money? [Video]
3/6/2023
03/06/23 Clinical Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more